Coherus Oncology (CHRS) Interest Coverage Ratio (2016 - 2025)
Coherus Oncology (CHRS) has disclosed Interest Coverage Ratio for 13 consecutive years, with 20.4 as the latest value for Q4 2025.
- Quarterly Interest Coverage Ratio fell 135.77% to 20.4 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 20.12 through Dec 2025, down 430.27% year-over-year, with the annual reading at 20.12 for FY2025, 377.55% down from the prior year.
- Interest Coverage Ratio hit 20.4 in Q4 2025 for Coherus Oncology, down from 19.07 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 57.03 in Q4 2024 to a low of 29.63 in Q1 2021.
- Historically, Interest Coverage Ratio has averaged 8.49 across 5 years, with a median of 8.0 in 2022.
- Biggest five-year swings in Interest Coverage Ratio: crashed 902.12% in 2021 and later soared 978.85% in 2024.
- Year by year, Interest Coverage Ratio stood at 6.83 in 2021, then rose by 19.63% to 5.49 in 2022, then decreased by 18.26% to 6.49 in 2023, then skyrocketed by 978.85% to 57.03 in 2024, then tumbled by 135.77% to 20.4 in 2025.
- Business Quant data shows Interest Coverage Ratio for CHRS at 20.4 in Q4 2025, 19.07 in Q3 2025, and 19.98 in Q2 2025.